These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4355038)

  • 81. Pharmacological differentiation between large and small coronary vessels.
    Tsukada T; Rubio R; Berne RM
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):255-67. PubMed ID: 6435555
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Release of catecholamines during the induction of and recovery from tachyphylaxis to angiotensin II.
    Cline WH
    J Pharmacol Exp Ther; 1971 Dec; 179(3):532-42. PubMed ID: 4332750
    [No Abstract]   [Full Text] [Related]  

  • 83. Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels.
    Mark AL; Abboud FM; Schmid PG; Heistad DD; Mayer HE
    J Clin Invest; 1972 Feb; 51(2):279-87. PubMed ID: 4400290
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.
    Winniford MD; Kennedy PL; Wells PJ; Hillis LD
    Circulation; 1986 Jan; 73(1):138-42. PubMed ID: 3079676
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparative effects of vasodilator drugs on large and small coronary resistance vessels in the dog.
    Forman R; Kirk ES
    Cardiovasc Res; 1980 Oct; 14(10):601-6. PubMed ID: 6783305
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition.
    Holtz J; Förstermann U; Pohl U; Giesler M; Bassenge E
    J Cardiovasc Pharmacol; 1984; 6(6):1161-9. PubMed ID: 6084775
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Physiology of the coronary circulation as a basis for evaluation of coronary dilators].
    Lochner W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):127-44. PubMed ID: 4979631
    [No Abstract]   [Full Text] [Related]  

  • 88. Androgen-induced enhancement of vascular reactivity.
    Greenberg S; George WR; Kadowitz PJ; Wilson WR
    Can J Physiol Pharmacol; 1974 Feb; 52(1):14-22. PubMed ID: 4363493
    [No Abstract]   [Full Text] [Related]  

  • 89. Development of tachyphylaxis to aspartyl and not asparginyl angiotensin II in the rat.
    Sambhi MP; Barrett JD
    Circ Res; 1967 Sep; 21(3):327-32. PubMed ID: 4293303
    [No Abstract]   [Full Text] [Related]  

  • 90. Pharmacological responses of the microvasculature of transplanted cardiac tissue.
    Cornish KG; Joyner WL; Gilmore JP
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1285-6. PubMed ID: 6819588
    [No Abstract]   [Full Text] [Related]  

  • 91. Uniformity of transmural perfusion in anesthetized dogs with maximally dilated coronary circulations.
    Downey HF; Bashour FA; Boatwright RB; Parker PE; Kechejian SJ
    Circ Res; 1975 Jul; 37(1):111-7. PubMed ID: 1149181
    [No Abstract]   [Full Text] [Related]  

  • 92. Vasomotor coronary oscillations: a model to evaluate autoregulation.
    Wong AY; Klassen GA
    Basic Res Cardiol; 1991; 86(5):461-75. PubMed ID: 1768245
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of adenosine on isolated coronary vascular smooth muscle.
    Norton JM; Gellai M; Detar R
    Pflugers Arch; 1972; 335(4):279-86. PubMed ID: 4628195
    [No Abstract]   [Full Text] [Related]  

  • 94. The dependence of the effects of i.cor. administered adenosine and of coronary conductance on the arterial pH, pCO 2 and buffer capacity in dogs.
    Raberger G; Weissel M; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(3):301-10. PubMed ID: 4257118
    [No Abstract]   [Full Text] [Related]  

  • 95. Effects of drugs and chemicals on subcellular organelles: mitochondrial contraction and coronary dilators.
    Rosenblum I
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):932-5. PubMed ID: 4630288
    [No Abstract]   [Full Text] [Related]  

  • 96. Evidence for myocardial conversion of angiotensin I.
    Gerlings ED; Gilmore JP
    Basic Res Cardiol; 1974; 69(3):222-7. PubMed ID: 4370010
    [No Abstract]   [Full Text] [Related]  

  • 97. Nitroglycerin and arterial compliance.
    Westling H; Anderson H
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 6():97-102. PubMed ID: 3098050
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of angiotensin I and antiotensin II on canine hepatic vascular resistance.
    Di Salvo J; Britton S; Galvas P; Sanders TW
    Circ Res; 1973 Jan; 32(1):85-92. PubMed ID: 4346144
    [No Abstract]   [Full Text] [Related]  

  • 99. Tachyphylaxis to alpha- and beta-angiotensin in dogs perfused with Ringer's solution or blood.
    Louis WJ; Jerums G
    Circ Res; 1968 Jan; 22(1):75-82. PubMed ID: 4294831
    [No Abstract]   [Full Text] [Related]  

  • 100. [Effect of nitroglycerin on the heart].
    Raff WK; Drechsel U; Scholtholt J; Lochner W
    Pflugers Arch; 1970; 317(4):336-43. PubMed ID: 4987283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.